Evidence map›Paper›PMID 30904982›Full record

ArticleLa Radiologia medica2019

Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.

Lorena Draghini, Sara Costantini, Lisa Vicenzi, Marco Italiani, Fabio Loreti, Fabio Trippa, Fabio Arcidiacono, Michelina Casale, Giovanna Mantello, Ernesto Maranzano

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Potential prognostic role of theStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lorena DraghiniRadiotherapy Oncology Centre, "S. Maria" Hospital, Terni, Italy.
Sara CostantiniRadiation Oncology Centre, Ospedali Riuniti Umberto I°, Ancona, Italy.
Lisa VicenziRadiation Oncology Centre, Ospedali Riuniti Umberto I°, Ancona, Italy.
Marco ItalianiRadiotherapy Oncology Centre, "S. Maria" Hospital, Terni, Italy.
Fabio LoretiNuclear Medicine Service, "S. Maria" Hospital, Terni, Italy.
Fabio TrippaRadiotherapy Oncology Centre, "S. Maria" Hospital, Terni, Italy.
Fabio ArcidiaconoRadiotherapy Oncology Centre, "S. Maria" Hospital, Terni, Italy.
Michelina CasaleRadiotherapy Oncology Centre, "S. Maria" Hospital, Terni, Italy.
Giovanna MantelloRadiation Oncology Centre, Ospedali Riuniti Umberto I°, Ancona, Italy.
Ernesto MaranzanoRadiotherapy Oncology Centre, "S. Maria" Hospital, Terni, Italy. e.maranzano@aospterni.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate toxicity and outcome of concomitant chemotherapy and intensity modulated radiotherapy (IMRT) with 18-fluorodeoxyglucose positron emission tomography/computed tomography (

methodsPatients with LACC underwent chemo-radiation with IMRT and SIB. Staging and follow-up were performed with clinical evaluation and CT, MRI,

resultsFourteen patients with cervical cancer were prospectively recruited between August 2014 and June 2017, 13 (93%) had a LACC, one (7%) patient was not evaluable because

conclusionsThe

Indexed as

Positron Emission Tomography Computed TomographyRadiotherapy, Intensity-ModulatedAdultAgedAged, 80 and overCombined Modality TherapyFemaleFluorodeoxyglucose F18HumansMiddle AgedNeoplasm StagingProspective StudiesRadiopharmaceuticalsTreatment OutcomeUterine Cervical NeoplasmsFluorodeoxyglucose F18Radiopharmaceuticals18FDG-PET/CTCervical cancerIMRTIntensity modulated radiotherapySimultaneous integrated boost

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.